Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kerem Ozer

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Endocrinology|October 13, 2009
Gene therapy with neurogenin 3 and betacellulin reverses major metabolic problems in insulin-deficient diabetic miceVijay Yechoor, Victoria Liu, Antoni Paul, et al.
BMJ Open Diabetes Research & Care|January 21, 2022
Flash glucose monitoring in type 2 diabetes managed with basal insulin in the USA: a retrospective real-world chart review study and meta-analysisAnders L Carlson, Timothy Dilon Daniel, Andrea DeSantis, et al.
Diabetes Care|October 17, 2013
Islet-specific T-cell responses and proinflammatory monocytes define subtypes of autoantibody-negative ketosis-prone diabetesBarbara M Brooks-Worrell, Dinakar Iyer, Ivonne Coraza, et al.
Metabolism: Clinical and Experimental|February 23, 2010
Presence or absence of a known diabetic ketoacidosis precipitant defines distinct syndromes of "A-β+" ketosis-prone diabetes based on long-term β-cell function, human leukocyte antigen class II alleles, and sex predilectionRamaswami Nalini, Kerem Ozer, Mario Maldonado, et al.
Diabetes, Obesity & Metabolism|March 27, 2026
Lower Risk of Cardiovascular Events in Patients With Clinical Atherosclerotic Cardiovascular Disease Who Initiated Semaglutide 2.4 mg in the Real-World: Results From the SCORE-Clinical ASCVD StudyMichael G Nanna, Carlos Mena-Hurtado, Victoria Divino, et al.
Diabetes|November 20, 2012
Pathogenesis of A⁻β⁺ ketosis-prone diabetesSanjeet G Patel, Jean W Hsu, Farook Jahoor, et al.
The Journal of Clinical Endocrinology and Metabolism|November 2, 2013
Anatabine supplementation decreases thyroglobulin antibodies in patients with chronic lymphocytic autoimmune (Hashimoto's) thyroiditis: a randomized controlled clinical trialLowell R Schmeltz, Thomas C Blevins, Stephen L Aronoff, et al.
JACC. Advances|February 9, 2025
Embracing Generative Artificial Intelligence in Clinical Research and Beyond: Opportunities, Challenges, and SolutionsHenry P Foote, Chuan Hong, Mohd Anwar, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Endocrinology|October 13, 2009
Gene therapy with neurogenin 3 and betacellulin reverses major metabolic problems in insulin-deficient diabetic miceVijay Yechoor, Victoria Liu, Antoni Paul, et al.
BMJ Open Diabetes Research & Care|January 21, 2022
Flash glucose monitoring in type 2 diabetes managed with basal insulin in the USA: a retrospective real-world chart review study and meta-analysisAnders L Carlson, Timothy Dilon Daniel, Andrea DeSantis, et al.
Diabetes Care|October 17, 2013
Islet-specific T-cell responses and proinflammatory monocytes define subtypes of autoantibody-negative ketosis-prone diabetesBarbara M Brooks-Worrell, Dinakar Iyer, Ivonne Coraza, et al.
Metabolism: Clinical and Experimental|February 23, 2010
Presence or absence of a known diabetic ketoacidosis precipitant defines distinct syndromes of "A-β+" ketosis-prone diabetes based on long-term β-cell function, human leukocyte antigen class II alleles, and sex predilectionRamaswami Nalini, Kerem Ozer, Mario Maldonado, et al.
Diabetes, Obesity & Metabolism|March 27, 2026
Lower Risk of Cardiovascular Events in Patients With Clinical Atherosclerotic Cardiovascular Disease Who Initiated Semaglutide 2.4 mg in the Real-World: Results From the SCORE-Clinical ASCVD StudyMichael G Nanna, Carlos Mena-Hurtado, Victoria Divino, et al.
Diabetes|November 20, 2012
Pathogenesis of A⁻β⁺ ketosis-prone diabetesSanjeet G Patel, Jean W Hsu, Farook Jahoor, et al.
The Journal of Clinical Endocrinology and Metabolism|November 2, 2013
Anatabine supplementation decreases thyroglobulin antibodies in patients with chronic lymphocytic autoimmune (Hashimoto's) thyroiditis: a randomized controlled clinical trialLowell R Schmeltz, Thomas C Blevins, Stephen L Aronoff, et al.
JACC. Advances|February 9, 2025
Embracing Generative Artificial Intelligence in Clinical Research and Beyond: Opportunities, Challenges, and SolutionsHenry P Foote, Chuan Hong, Mohd Anwar, et al.
Pageof 2